Indiana’s laws requiring hospitals to release price information are woefully inadequate, according to a report by two health insurance reform groups. Indiana was among 29 states to receive an "F" grade.
An Indiana House panel has altered a plan that would use the state's Healthy Indiana Plan to expand Medicaid coverage in the state.
Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals including Eli Lilly and Co. that are developing similar medicines.
The biggest changes from President Obama’s 2010 health reform law take effect nine months from now, so many Hoosier employers have started crunching detailed numbers to cost out their options.
A study by the nation's leading group of financial risk analysts shows the biggest driver of health insurance premiums will rise by more than 67 percent for Indiana residents' individual policies under President Barack Obama's health care overhaul.
Eli Lilly and Co. said Monday that it has submitted a new type 2 diabetes treatment it is developing with German drugmaker Boehringer Ingelheim to the Food and Drug Administration.
Consumers would face tighter limits on the quantities they could buy of cold and allergy pills often used to make methamphetamine under a proposal approved by Indiana lawmakers.
The Indiana Health Information Exchange Inc. hopes to raise roughly $20 million over three years to take its health information technology services to hospitals around the country.
Gov. Mike Pence’s strategy for expanding Medicaid in Indiana is to convince or cajole the Obama administration to let him use the Healthy Indiana Plan to do it. A recent deal in Arkansas seems to make it more likely that the Obama team will give Pence what he wants.
Eli Lilly and Co. granted larger bonuses to its top five executives early this year, which boosted their 2012 compensation anywhere from 3 percent to 8 percent.
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines.
Anderson-based Coeus Technology has invented a chemical that kills dangerous bacteria, including potentially deadly staph, by forming a germ-killing barrier that lasts two weeks to six months.
Hospital officials praised Indiana's medical savings accounts but some consumer advocates panned them Wednesday during a public hearing as Gov. Mike Pence seeks federal approval to use the Healthy Indiana Plan to expand Medicaid in this state.
The debate over expanding Medicaid in Indiana so far has hinged on how much it will cost. But two recent studies suggest Hoosier employers should be focused on how much a Medicaid expansion will save them: perhaps as much as $400 million per year.
House Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s physician before automatically substituting a generic version of a biotech drug for a brand-name version.
Indiana lawmakers are advancing a bill that would make it illegal to possess or deal "lookalike" synthetic drugs similar to those known as "bath salts" and other nicknames.
The federal government has delayed action on Indiana's proposal to expand Medicaid because the state hasn't received public comment on the proposals, but the issue could be resolved quickly with two hearings set for next week, a spokeswoman for Gov. Mike Pence said Wednesday.
Purdue University said Tuesday that Indiana farmers received payouts for 2012 corn, soybean and wheat losses that are nearly twice as much as the previous record of $522 million in 2008.
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters and manufacturing facility to Noblesville.
More than two dozen of the world's largest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs.
